Gunma, Japan

Kazushi Kanatani

This inventor holds 1 USPTO granted patent. Top assignee: Japan Immunoresearch Laboratories Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazushi Kanatani. Retrieved from https://idiyas.com/inventor/kazushi-kanatani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazushi Kanatani: Innovator in Lipid Metabolism

Introduction

Kazushi Kanatani is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of lipid metabolism through his innovative research and patents. His work focuses on high-density lipoprotein-reactive peptides, which have potential applications in treating various diseases.

Latest Patents

Kazushi Kanatani holds a patent for high-density lipoprotein-reactive peptides. This patent describes a peptide that comprises an amino acid sequence capable of specifically binding to high-density lipoprotein cholesterol or withdrawing cholesterol from foam cells. The peptides developed by Kanatani are useful as drugs for diseases caused by arteriosclerosis, lipid metabolic errors, and peripheral cholesterosis.

Career Highlights

Kanatani is associated with Japan Immunoresearch Laboratories Co., Ltd., where he continues to advance his research in lipid metabolism. His work has garnered attention for its potential impact on health and medicine.

Collaborations

He collaborates with notable colleagues, including Manabu Niimi and Masakazu Adachi, who contribute to his research endeavors.

Conclusion

Kazushi Kanatani's innovative work in high-density lipoprotein-reactive peptides showcases his commitment to advancing medical science. His contributions have the potential to lead to significant advancements in the treatment of lipid-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…